< Back to previous page
Organisation
Clinical Pharmacology and Pharmacotherapy
Division
Main organisation:Department of Pharmaceutical and Pharmacological Sciences
Lifecycle:1 Jul 2013 → Today
Organisation profile:
The area of interest of the research group Clinical Pharmacology and Pharmacotherapy is the safe and efficient use of medicinal products – including small molecules, biologicals and vaccines – in humans.
Keywords:Pharmacology
Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Current researchers
1 - 10 of 60 results
- Khadidja Abdallah (Member)
- Dorien Bamps (Member)
- Liese Barbier (Member)
- Teresa Barcina Lacosta (Member)
- Alessandra Blonda (Member)
- Elif Car (Member)
- Minne Casteels (Member)
- Michael Ceulemans (Member)
- Zilke Claessens (Member)
Projects
1 - 10 of 158
- Immunotherapy based on repurposed drugs to combat ovarian cancerFrom1 Jan 2026 → TodayFunding: Foundations, funds and other with scientific goal
- Patient-centred decision-making for rare diseasesFrom1 Oct 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- 3D printed gastroretentive dosage forms for timed multidrug release (3Dose)From1 Oct 2025 → TodayFunding: IOF - technology validation in lab
- Big data and small farmers: The European agricultural data space confronted with smallholder knowledge practices.From1 Oct 2025 → TodayFunding: BOF - postdoctoral mandates
- A patient-informed clinical platform to inform patient-centered decision-making for rare diseases (INFORM-RD)From1 Oct 2025 → TodayFunding: Fund Recuperation Fiscal Exemption
- Population pharmacogenomics as a strategy to attain health equity, applied to EthiopiaFrom29 Sep 2025 → TodayFunding: BOF - doctoral mandates
- Harnessing real-world data to improve medication safety in older adults: insights from the ASPIRE databaseFrom19 Sep 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Medication use and safety related to the pharmacological management of immune-mediated inflammatory diseases before, during and after pregnancyFrom18 Sep 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Stakeholder Engagement & Regulatory Frameworks in Patient-Centred EvidenceFrom16 Sep 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PUBLIC ENGAGEMENT IN RESEARCH INFRASTRUCTURES FOR MISSION CANCER: MANAGING COMPLEXITY OF EMERGING TECHNOLOGIESFrom1 Sep 2025 → TodayFunding: HORIZON.2.1 - Health
Publications
1 - 10 of 2036
- Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial(2018)Published in: Clinical Infectious DiseasesISSN: 1058-4838Issue: 3Volume: 66Pages: 444 - 451
- Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology(2017)Published in: European Journal of Pharmaceutical SciencesISSN: 0928-0987Volume: 109Pages: S27 - S31
- Navigating the twilight zone of DOAC plasma monitoring(2023)Published in: THROMBOSIS RESEARCHISSN: 0049-3848Volume: 225Pages: 101 - 102
- Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium(2017)Published in: Research in Social and Administrative PharmacyISSN: 1551-7411Issue: 1Volume: 13Pages: 98 - 108
- The value and limitations of new oral anticoagulant plasma level assessments(2022)Published in: EUROPEAN HEART JOURNAL SUPPLEMENTSISSN: 1520-765XIssue: Suppl AVolume: 24Pages: A32 - A41
- An open label study to evaluate the single dose pharmacokinetics, safety and tolerability of doripenem in infants less than 12 weeks chronological age(2015)Published in: Antimicrobial Agents and ChemotherapyISSN: 0066-4804Issue: 8Volume: 59Pages: 4742 - 4749
- Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis(2017)Published in: PharmacoeconomicsISSN: 1170-7690Issue: 10Volume: 35Pages: 1047 - 1062
- Using Graph Theory to Assess the Interaction Between Cerebral Function, Brain Hemodynamics and Systemic Variables in Premature Infants(2018)Published in: ComplexityISSN: 1076-2787Volume: 2018
- RVCL-S and CADASIL display distinct impaired vascular function(2018)Published in: NEUROLOGYISSN: 0028-3878Issue: 10Volume: 91Pages: E956 - E963
- Current Data on COVID-19 mRNA-Vaccine Safety During Pregnancy Might be Subject to Selection Bias(2021)Published in: VirusesISSN: 1999-4915Issue: 8Volume: 13